Market Research Logo

CNS/Neurology Market Research Reports & Industry Analysis

Neurology and the CNS is the branch of science dealing with anatomy, function, diagnosis and treatment of disorders and disease affecting the central nervous system (brain and spinal cord). Neuroscience medicine includes but is not limited to the study and treatment of Alzheimer’s disease, major depressive disorder, schizophrenia, Parkinson’s disease, epilepsy/seizures, migraine, insomnia/sleep disorders, bipolar disorder, and ADHD.

A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.

Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

CNS/Neurology Industry Research & Market Reports

  • Mild Cognitive Impairment - Pipeline Review, H1 2017

    ...Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an intermediate stage between the expected cognitive decline of ... Read More

  • Depression - Pipeline Review, H1 2017

    ...Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anxiety, agitation or restlessness ... Read More

  • Tinnitus - Pipeline Review, H1 2017

    ...landscape. Tinnitus is a condition characterized by ringing, swishing, or other noises that originating in the ear or head. Causes of tinnitus are age-related hearing loss, exposure to loud noises, earwax blockage in the ear ... Read More

  • Brain Cancer Treatment Drugs Companies in China

    ...pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing ... Read More

  • Brain Cancer Treatment Drugs Markets in China

    ...to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new ... Read More

  • Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021)

    ...injectable anti-psychotic market, with detailed analysis of market size and growth, and segmentation of the industry. The report also includes a detailed regional analysis of the long acting injectable anti-psychotic market in the region of ... Read More

  • Global Psychiatry Partnering 2010-2017: Deal trends, players and financials

    ...in Psychiatry partnering deals Financial deal terms for headline, upfront and royalty by stage of development Psychiatry partnering agreement structure Psychiatry partnering contract documents Top Psychiatry deals by value Most active Psychiatry dealmakers Most of ... Read More

  • Global Brain Cancer Partnering 2010 to 2017

    ...companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More

  • Global Neuropathy Partnering 2010 to 2017

    ...Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More

  • Global Schizophrenia Partnering 2010 to 2017

    ...Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More

  • Global Depression Partnering 2010 to 2017

    ...Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More

  • Global Bipolar Disorder Partnering 2010-2017

    ...Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More

  • Global Autism Partnering 2010-2017

    ...partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ... Read More

  • Global Drug Addiction Partnering 2010 to 2017

    ...companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More

  • Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials

    ...and biotechnology companies since 2010. Trends in Central Nervous System partnering deals Financial deal terms for headline, upfront and royalty by stage of development Central Nervous System partnering agreement structure Central Nervous System partnering contract ... Read More

  • Global Traumatic Brain Injury Partnering 2010 to 2017

    ...leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering ... Read More

  • Global Motor Neurone Disease Partnering 2010 to 2017

    ...leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering ... Read More

  • Global Migraine Partnering 2010 to 2017

    ...Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More

  • Global Dementia Partnering 2010 to 2017

    ...Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More

  • Global Anxiety Partnering 2010-2017

    ...partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by ... Read More

  • Global Attention Deficit Disorder Partnering 2010-2017

    ...companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More

  • Global Learning Disability Partnering 2010 to 2017

    ...companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More

  • Global Hearing Disorders Partnering 2010 to 2017

    ...companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More

  • Anorexia Nervosa Global Clinical Trials Review, H1, 2017

    ...line data relating to the clinical trials on Anorexia Nervosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More

  • Alcohol Addiction Global Clinical Trials Review, H1, 2017

    ...line data relating to the clinical trials on Alcohol Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More

1 2 4 6 7 8 9 10